Neogen Corp. Stock Hits Day Low of $5.57 Amid Price Pressure

Neogen Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant decline today, with its stock price dropping by 7.1%. The stock reached an intraday low of USD 5.57, reflecting ongoing challenges in its performance metrics.
Over the past year, Neogen Corp. has faced a substantial downturn, with a staggering 62.64% decrease in returns, significantly underperforming the S&P 500, which has gained 17.82% in the same period. The company's year-to-date performance also shows a decline of 53.62%, further highlighting its struggles in the current market environment.

Financial indicators reveal a concerning picture for Neogen Corp. The return on capital employed (ROCE) stands at a low -41.88%, while the debt-equity ratio is notably high at 37.83%. Additionally, the interest coverage ratio is at 130.73, indicating potential difficulties in meeting financial obligations.

Overall, Neogen Corp.'s performance metrics suggest a challenging landscape, with both short-term and long-term results falling short of expectations.